These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1355960)

  • 21. A candidate phocid herpesvirus vaccine that provides protection against feline herpesvirus infection.
    Martina BE; Airikkala MI; Harder TC; van Amerongen G; Osterhaus AD
    Vaccine; 2001 Dec; 20(5-6):943-8. PubMed ID: 11738761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homologous and heterologous antibody responses of mice immunized with purified feline herpesvirus type 1 and canine herpesvirus glycoproteins.
    Limcumpao JA; Horimoto T; Xuan XN; Tohya Y; Azetaka M; Takahashi E; Mikami T
    J Vet Med Sci; 1991 Jun; 53(3):423-32. PubMed ID: 1832031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homology between feline herpesvirus-1 and canine herpesvirus.
    Rota PA; Maes RK
    Arch Virol; 1990; 115(1-2):139-45. PubMed ID: 2174232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro recombination of feline herpesvirus type 1.
    Fujita K; Maeda K; Yokoyama N; Miyazawa T; Kai C; Mikami T
    Arch Virol; 1998; 143(1):25-34. PubMed ID: 9505964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of the S1 gene of 4/91 type infectious bronchitis virus isolated in Japan.
    Shimazaki Y; Watanabe Y; Harada M; Seki Y; Kuroda Y; Fukuda M; Honda E; Suzuki S; Nakamura S
    J Vet Med Sci; 2009 May; 71(5):583-8. PubMed ID: 19498283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of interfering RNAs targeted against feline herpesvirus 1 glycoprotein D for inhibition of feline herpesvirus 1 infection of feline kidney cells.
    Wilkes RP; Kania SA
    Am J Vet Res; 2009 Aug; 70(8):1018-25. PubMed ID: 19645584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens.
    Kanellos T; Sutton DJ; Salisbury CF; Chalmers WS
    J Feline Med Surg; 2008 Aug; 10(4):346-54. PubMed ID: 18448375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant feline herpesvirus type 1 expressing immunogenic proteins inducible virus neutralizing antibody against feline calicivirus in cats.
    Yokoyama N; Maeda K; Tohya Y; Kawaguchi Y; Fujita K; Mikami T
    Vaccine; 1996 Dec; 14(17-18):1657-63. PubMed ID: 9032896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.
    von Einem J; Wellington J; Whalley JM; Osterrieder K; O'Callaghan DJ; Osterrieder N
    J Virol; 2004 Mar; 78(6):3003-13. PubMed ID: 14990719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the feline herpesvirus type 1 (FHV-1) genes encoding glycoproteins G, D, I and E: expression of FHV-1 glycoprotein D in vaccinia and raccoon poxviruses.
    Spatz SJ; Rota PA; Maes RK
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1235-44. PubMed ID: 8207390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan.
    Ohe K; Sakai S; Takahasi T; Sunaga F; Murakami M; Kiuchi A; Fukuyama M; Furuhata K; Hara M; Ishikawa Y; Taneno A
    Vet Res Commun; 2007 May; 31(4):497-507. PubMed ID: 17225086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of gene deletion mutants of Cyprinid herpesvirus 3 (koi herpesvirus) lacking the immunogenic envelope glycoproteins pORF25, pORF65, pORF148 and pORF149.
    Schröder L; Klafack S; Bergmann SM; Lee PA; Franzke K; Höper D; Mettenleiter TC; Fuchs W
    Virus Res; 2019 Feb; 261():21-30. PubMed ID: 30543872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
    Scott FW; Geissinger CM
    Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feline panleukopenia virus, feline herpesvirus-1 and feline calicivirus antibody responses in seronegative specific pathogen-free kittens after parenteral administration of an inactivated FVRCP vaccine or a modified live FVRCP vaccine.
    Lappin MR
    J Feline Med Surg; 2012 Feb; 14(2):161-4. PubMed ID: 22314095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial.
    Jas D; Frances-Duvert V; Vernes D; Guigal PM; Poulet H
    Vet Microbiol; 2015 May; 177(1-2):123-31. PubMed ID: 25824128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
    Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
    Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycoprotein-specific immune response in canine herpesvirus infection.
    Xuan X; Horimoto T; Limcumpao JA; Tohya Y; Takahashi E; Mikami T
    Arch Virol; 1992; 122(3-4):359-65. PubMed ID: 1309997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients.
    Hayakawa Y; Torigoe S; Shiraki K; Yamanishi K; Takahashi M
    J Infect Dis; 1984 Jun; 149(6):956-63. PubMed ID: 6330239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
    Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
    J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.